| Pharmaceutical active ingredients: |
| Bretylium |
| Available forms, composition and doses of Darenthin: |
| N / A |
| Darenthin medical category: |
| Human:Class III antiarrythmics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C01BD02 - Bretylium Tosilate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Darachlor | Pyrimethamine | Unidentified Pharmaceutical Company |
| Darammon | Ammonium Chloride | Unidentified Pharmaceutical Company |
| Darapram | Pyrimethamine | Unidentified Pharmaceutical Company |
| Dar-Chem 14 | Stearic Acid | Unidentified Pharmaceutical Company |
| Darco | Carbon Black | Unidentified Pharmaceutical Company |
| Darentin | Bretylium | Unidentified Pharmaceutical Company |
| Darid QH | Alginic Acid (Alginate Sodium) | Unidentified Pharmaceutical Company |
| Dariloid QH | Alginic Acid (Alginate Sodium) | Unidentified Pharmaceutical Company |
| Darolon | Acecarbromal | Unidentified Pharmaceutical Company |
| D-Arthin | Vitamin D2 | Unidentified Pharmaceutical Company |